Urothelial cancer stem cells and epithelial plasticity: current concepts and therapeutic implications in bladder cancer

Cancer and Metastasis Reviews

Volumn 34, Issue 4, 2015, Pages 691-701

  Garg, Minal ^a  

^a UNIVERSITY OF LUCKNOW   (India)

Author keywords

Cancer progression; Cancer stemness; Cancer therapy; Epithelial to mesenchymal transition; Urothelial cell carcinoma

Indexed keywords

ABC TRANSPORTER; ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN RELATED CELL ADHESION MOLECULE 6; CYTOKERATIN 17; CYTOKERATIN 5; EPIDERMAL GROWTH FACTOR RECEPTOR; IMMUNOMODULATING AGENT; LAMININ RECEPTOR; MICRORNA 200; MICRORNA 205; UROPLAKIN 2;

BASEMENT MEMBRANE; BLADDER CANCER; BLADDER CANCER CELL LINE; CANCER GROWTH; CANCER RECURRENCE; CANCER STEM CELL; CARCINOGENICITY; CELL DIFFERENTIATION; CELL PLASTICITY; CHROMOSOME INACTIVATION; CYSTECTOMY; EPITHELIAL MESENCHYMAL TRANSITION; HUMAN; MALIGNANT TRANSFORMATION; NONHUMAN; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; TRANSITIONAL CELL CARCINOMA; WNT SIGNALING PATHWAY; BLADDER; BLADDER TUMOR; CELL TRANSFORMATION; CYTOLOGY; DISEASE COURSE; EPITHELIUM CELL; PATHOLOGY; PHYSIOLOGY; UROTHELIUM;

CARCINOMA, TRANSITIONAL CELL; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HUMANS; NEOPLASTIC STEM CELLS; URINARY BLADDER; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84958851217     PISSN: 01677659     EISSN: 15737233     Source Type: Journal    
DOI: 10.1007/s10555-015-9589-6     Document Type: Review

References (39)

1. van der Horst, G., Bos, L., & van der Pluijm, G. (2012). Epithelial plasticity, cancer stem cells, and the tumor-supportive stroma in bladder carcinoma. Molecular Cancer Research, 10(8), 995–1009.
2. Castillo-Martin, M., Domingo-Domenech, J., Karni-Schmidt, O., Matos, T., & Cordon-Cardo, C. (2010). Molecular pathways of urothelial development and bladder tumorigenesis. Urologic Oncology, 28(4), 401–408.
3. Brandt, W. D., Matsui, W., Rosenberg, J. E., He, X., Ling, S., Schaeffer, E. M., & Berman, D. M. (2009). Urothelial carcinoma: stem cells on the edge. Cancer and Metastasis Reviews, 28(3–4), 291–304.
4. Kurzrock, E. A., Lieu, D. K., Degraffenried, L. A., Chan, C. W., & Isseroff, R. R. (2008). Label-retaining cells of the bladder: candidate urothelial stem cells. American Journal of Physiology. Renal Physiology, 294(6), F1415-21.
5. Hatina, J., & Schulz, W. A. (2012). Stem cells in the biology of normal urothelium and urothelial carcinoma. Neoplasma, 59(6), 728–736.
6. Ho, P. L., Kurtova, A., & Chan, K. S. (2012). Normal and neoplastic urothelial stem cells: getting to the root of the problem. Nature Reviews. Urology, 9(10), 583–594.
7. Thangappan, R., & Kurzrock, E. A. (2009). Three clonal types of urothelium with different capacities for replication. Cell Proliferation, 42(6), 770–779.
8. Ning, Z. F., Huang, Y. J., Lin, T. X., Zhou, Y. X., Jiang, C., Xu, K. W., Huang, H., Yin, X. B., & Huang, J. (2009). Subpopulations of stem-like cells in side population cells from the human bladder transitional cell cancer cell line T24. The Journal of International Medical Research, 37(3), 621–630.
9. She, J. J., Zhang, P. G., Wang, Z. M., Gan, W. M., & Che, X. M. (2008). Identification of side population cells from bladder cancer cells by DyeCycle Violet staining. Cancer Biology & Therapy, 7(10), 1663–1668.
10. Chan, K. S., Espinosa, I., Chao, M., Wong, D., Ailles, L., Diehn, M., Gill, H., Presti, J., Jr., Chang, H. Y., van de Rijn, M., Shortliffe, L., & Weissman, I. L. (2009). Identification, molecular characterization, clinical prognosis, and therapeutic targeting of human bladder tumor-initiating cells. Proceedings of the National Academy of Sciences of the United States of America, 106(33), 14016–14021.
11. Yang, Y. M., & Chang, J. W. (2008). Bladdercancer initiating cells (BCICs) are among EMA-CD44v6+ subset: novel methods for isolating undetermined cancer stem (initiating) cells. Cancer Investigation, 26(7), 725–733.
12. He, X., Marchionni, L., Hansel, D. E., Yu, W., Sood, A., Yang, J., Parmigiani, G., Matsui, W., & Berman, D. M. (2009). Differentiation of a highly tumorigenic basal cell compartment in urothelial carcinoma. Stem Cells, 27(7), 1487–1495.
13. Su, Y., Qiu, Q., Zhang, X., Jiang, Z., Leng, Q., Liu, Z., Stass, S. A., & Jiang, F. (2010). Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiology, Biomarkers & Prevention, 19(2), 327–337.
14. Bentivegna, A., Conconi, D., Panzeri, E., Sala, E., Bovo, G., Viganò, P., Brunelli, S., Bossi, M., Tredici, G., Strada, G., & Dalprà, L. (2009). Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples. Cancer Science, 101(2), 416–424.
15. Oates, J. E., Grey, B. R., Addla, S. K., Samuel, J. D., Hart, C. A., Ramani, V. A., Brown, M. D., & Clarke, N. W. (2009). Hoechst 33342 side population identification is a conserved and unified mechanism in urological cancers. Stem Cells and Development, 18(10), 1515–1522.
16. Massard, C., Deutsch, E., & Soria, J. C. (2006). Tumor stem cell-targeted treatment: elimination or differentiation. Annals of Oncology, 17(11), 1620–1624.
17. Shin, K., Lee, J., Guo, N., Kim, J., Lim, A., Qu, L., Mysorekar, I. U., & Beachy, P. A. (2011). Hedgehog/Wnt feedback supports regenerative proliferation of epithelial stem cells in bladder. Nature, 472(7341), 110–114.
18. Herzig, M., Savarese, F., Novatchkova, M., Semb, H., & Christofori, G. (2007). Tumor progression induced by the loss of E-cadherin independent of beta catenin/Tcf-mediated Wnt signaling. Oncogene, 26, 2290–2298.
19. Suyama, K., Shapiro, I., Guttman, M., & Hazan, R. B. (2002). A signaling pathway leading to metastasis is controlled by N-cadherin and the FGF receptor. Cancer Cell, 2, 301–314.
20. Mandeville, J. A., Silva, N. B., Vanni, A. J., Smith, G. L., Rieger-Christ, K. M., Zeheb, R., Loda, M., Libertino, J. A., & Summerhayes, I. C. (2008). P-cadherin as a prognostic indicator and a modulator of migratory behavior in bladder carcinoma cells. BJU International, 102, 1707–1714.
21. Islam, S. S., Mokhtari, R. B., Noman, A. S., Uddin, M., Rahman, M. Z., Azadi, M. A., Zlotta, A., van der Kwast, T., Yeger, H., & Farhat, W. A. (2015). Sonic hedgehog (Shh) signaling promotes tumorigenicity and stemness via activation of epithelial-to-mesenchymal transition (EMT) in bladder cancer. Molecular Carcinogenesis. doi:10.1002/mc.22300.
22. Fondrevelle, M. E., Kantelip, B., Reiter, R. E., Chopin, D. K., Thiery, J. P., Monnien, F., Bittard, H., & Wallerand, H. (2009). The expression of Twist has an impact on survival in human bladder cancer and is influenced by the smoking status. Urologic Oncology, 27, 268–276.
23. Garg, M. (2013). Epithelial-mesenchymal transition—activating transcription factors—multifunctional regulators in cancer. World Journal of Stem Cells, 5(4), 188–195.
24. Yu, Q., Zhang, K., Wang, X., Liu, X., & Zhang, Z. (2010). Expression of transcription factors snail, slug, and twist in human bladder carcinoma. Journal of Experimental & Clinical Cancer Research, 29, 119.
25. Bruyere, F., Namdarian, B., Corcoran, N. M., Pedersen, J., Ockrim, J., Voelzke, B. B., Mete, U., Costello, A. J., & Hovens, C. M. (2010). Snail expression is an independent predictor of tumor recurrence in superficial bladder cancers. Urologic Oncology, 28, 591–596.
26. Zhao, D., Besser, A. H., Wander, S. A., Sun, J., Zhou, W., Wang, B., Ince, T., Durante, M. A., Guo, W., Mills, G., Theodorescu, D., & Slingerland, J. (2015). Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation. Oncogene. doi:10.1038/onc.2014.473.
27. Garg, M. (2015). Targeting microRNAs in epithelial-to-mesenchymal transition-induced cancer stem cells: therapeutic approaches in cancer. Expert Opinion on Therapeutic Targets, 19(2), 285–297.
28. Majid, S., Dar, A. A., Saini, S., Deng, G., Chang, I., Greene, K., Tanaka, Y., Dahiya, R., & Yamamura, S. (2013). MicroRNA-23b functions as a tumor suppressor by regulating Zeb1 in bladder cancer. PloS One, 8(7), e67686.
29. Wiklund, E. D., Bramsen, J. B., Hulf, T., Dyrskjøt, L., Ramanathan, R., Hansen, T. B., Villadsen, S. B., Gao, S., Ostenfeld, M. S., Borre, M., Peter, M. E., Ørntoft, T. F., Kjems, J., & Clark, S. J. (2011). Coordinated epigenetic repression of the miR-200 family and miR-205 in invasive bladder cancer. International Journal of Cancer, 128(6), 1327–1334.
30. Garg, M. (2014). Prognostic and therapeutic applications of the molecular events in clinical management of urothelial carcinoma of bladder. Journal of Experimental and Therapeutic Oncology, 10(4), 301–316.
31. Zhang, Y., Wang, Z., Yu, J., Jz, S., Wang, C., Wh, F., Zw, C., & Yang, J. (2012). Cancer stem-like cells contribute to cisplatin resistance and progression in bladder cancer. Cancer Letters, 322(1), 70–77.
32. Massari F, Ciccarese C, Santoni M, Brunelli M, Conti A, Modena A, Montironi R, Santini D, Cheng L, Martignoni G, Cascinu S, Tortora G (2015). The route to personalized medicine in bladder cancer: where do we stand? Target Oncology
33. Adam, L., Zhong, M., Choi, W., Qi, W., Nicoloso, M., Arora, A., Calin, G., Wang, H., Siefker-Radtke, A., McConkey, D., Bar-Eli, M., & Dinney, C. (2009). miR-200 expression regulates epithelial-to-mesenchymal transition in bladder cancer cells and reverses resistance to epidermal growth factor receptor therapy. Clinical Cancer Research, 15(16), 5060–5072.
34. Singh, S. V., & Singh, K. (2012). Cancer chemoprevention with dietary isothiocyanates mature for clinical translational research. Carcinogenesis, 33(10), 1833–1842.
35. Wu, K., Ning, Z., Zeng, J., Fan, J., Zhou, J., Zhang, T., Zhang, L., Chen, Y., Gao, Y., Wang, B., Guo, P., Li, L., Wang, X., & He, D. (2013). Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness. Cellular Signalling, 25(12), 2625–2633.
36. Katoh, M., & Nakagama, H. (2014). FGF receptors: cancer biology and therapeutics.Med. Research Reviews, 34(2), 280–300.
37. Chan, E., Patel, A., Heston, W., & Larchian, W. (2009). Mouse orthotopic models for bladder cancer research. BJU International, 104(9), 1286–1291.
38. Zhang, Z. T., Pak, J., Shapiro, E., Sun, T. T., & Wu, X. R. (1999). Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Research, 59(14), 3512–3517.
39. Kenny, P. A., Lee, G. Y., & Bissell, M. J. (2007). Targeting the tumor microenvironment. Frontiers in Bioscience, 12, 3468–3474.